Theravance Biopharma, Inc.
Hedge Funds Holdings
Last updated:
Theravance Biopharma, Inc.‘s stocks are currently a part of 70 hedge funds’ portfolios, which represents 52.62% of the total amount of its stocks outstanding. This makes up a total of 38.72M shares of Theravance Biopharma, Inc.. Compared to the previous quarter, the number fell by -37.57% or -23.30M shares fewer. As for the holding position changes, 31.43% (22) of current hedge fund investors increased the number of shares held, 32.86% (23) of current holders sold a part of the shares held, and 8.57% (6) closed the holdings completely. 7 hedge funds are new holders of Theravance Biopharma, Inc. stock in Q1 2023, it is 10% of total holders.
Hedge funds holding Theravance Biopharma (Q2 2018 – Q1 2023)
| Q2 2018 | 86 |
|---|---|
| Q3 2018 | 89 |
| Q4 2018 | 93 |
| Q1 2019 | 98 |
| Q2 2019 | 92 |
| Q3 2019 | 88 |
| Q4 2019 | 103 |
| Q1 2020 | 103 |
| Q2 2020 | 122 |
| Q3 2020 | 114 |
| Q4 2020 | 102 |
| Q1 2021 | 104 |
| Q2 2021 | 104 |
| Q3 2021 | 110 |
| Q4 2021 | 110 |
| Q1 2022 | 115 |
| Q2 2022 | 106 |
| Q3 2022 | 117 |
| Q4 2022 | 117 |
| Q1 2023 | 70 |
Hedge funds changes in Theravance Biopharma positions (Q2 2018 – Q1 2023)
| Q2 2018 | 9 | 30 | 28 | 11 | 8 |
|---|---|---|---|---|---|
| Q3 2018 | 17 | 31 | 20 | 11 | 10 |
| Q4 2018 | 17 | 38 | 22 | 13 | 3 |
| Q1 2019 | 18 | 35 | 20 | 13 | 12 |
| Q2 2019 | 12 | 37 | 21 | 16 | 6 |
| Q3 2019 | 11 | 37 | 25 | 15 | 0 |
| Q4 2019 | 28 | 33 | 26 | 7 | 9 |
| Q1 2020 | 19 | 51 | 18 | 18 | -3 |
| Q2 2020 | 34 | 42 | 28 | 12 | 6 |
| Q3 2020 | 12 | 35 | 50 | 19 | -2 |
| Q4 2020 | 13 | 33 | 32 | 26 | -2 |
| Q1 2021 | 15 | 29 | 39 | 12 | 9 |
| Q2 2021 | 19 | 41 | 26 | 19 | -1 |
| Q3 2021 | 32 | 40 | 20 | 25 | -7 |
| Q4 2021 | 22 | 45 | 28 | 21 | -6 |
| Q1 2022 | 18 | 41 | 36 | 14 | 6 |
| Q2 2022 | 10 | 34 | 42 | 16 | 4 |
| Q3 2022 | 23 | 43 | 28 | 13 | 10 |
| Q4 2022 | 20 | 39 | 39 | 20 | -1 |
| Q1 2023 | 7 | 22 | 23 | 6 | 12 |
Hedge funds changes in Theravance Biopharma stock options (Q2 2018 – Q1 2023)
| Q2 2018 | 2,207,000 | 537,000 |
|---|---|---|
| Q3 2018 | 1,685,000 | 983,000 |
| Q4 2018 | 245,000 | 0 |
| Q1 2019 | 220,000 | 13,256,000 |
| Q2 2019 | 2,258,000 | 17,268,000 |
| Q3 2019 | 1,835,000 | 789,000 |
| Q4 2019 | 726,000 | 1,331,000 |
| Q1 2020 | 1,521,000 | 2,856,000 |
| Q2 2020 | 39,000 | 1,026,000 |
| Q3 2020 | 877,000 | 1,039,000 |
| Q4 2020 | 69,000 | 1,000 |
| Q1 2021 | 2,720,000 | 2,110,000 |
| Q2 2021 | 1,451,000 | 838,000 |
| Q3 2021 | 8,440,000 | 4,481,000 |
| Q4 2021 | 978,000 | 4,144,000 |
| Q1 2022 | 1,490,000 | 5,714,000 |
| Q2 2022 | 1,282,000 | 1,238,000 |
| Q3 2022 | 9,476,000 | 4,190,000 |
| Q4 2022 | 13,216,846 | 1,632,918 |
| Q1 2023 | 111,472,000 | 21,767,000 |